Market Overview

BIO Announces Programming for the 17th Annual BIO Investor Forum

Share:

Healthy investment climate sets backdrop for the annual meeting

The Biotechnology
Innovation Organization
(BIO) today unveiled programming for its
upcoming BIO
Investor Forum
to be held October 17-18 at the Westin St. Francis
Hotel in San Francisco.

Held annually for the past 16 years, the event focuses on investment
trends for early-stage biotechnology companies and attracts investors,
business development executives and other stakeholders within the sector.

"Investment activity in the biotech market has been strong all year"
said Jim Greenwood, President and CEO of BIO. "This conference is a
central meeting place for research analysts, investment bankers and
industry executives looking for funding opportunities that could support
future medical breakthroughs. Enthusiasm for emerging biotechnology
companies can be seen in the list of investors coming to this event from
all over the world, particularly Asia. I am looking forward to another
very successful BIO Investor Forum."

The list of panel discussions announced today will fall into
business/public policy or therapeutic topics. Detailed descriptions can
be found on BIO's
website
.

Business Sessions:

  • Learning from Translational Research Successes to Attract Investment
  • Reaching Chinese Investors: Considerations for an IPO in Hong Kong
  • Policy Outlook—Implications of the Trump Administration's Healthcare
    Initiatives
  • View from the Board: Responding to an Acquisition Offer
  • "Digiceuticals" as a New Class of FDA-Approved Therapeutics:
    Investment & Partnering Opportunities
  • Applying Artificial Intelligence to Improve Therapy Development Today
  • Market Outlook – IPOs Ascendant and Watching M&A Valuations

Therapeutic Panels:

  • Navigating Checkpoint Inhibitors' Clinical Results: Lessons for CEOs
    and Investors
  • Using Microbiome-Based Therapies to Improve Patient Outcomes
  • Expanding the Toolbox of Neurodegeneration Therapies
  • How Real-World Evidence Can Improve Clinical Trial Productivity

Over 170 companies will deliver 15-minute presentations on their
technology and product pipelines and approximately 2,700 meetings will
be scheduled through BIO's One-on-One Partnering™ putting emerging
companies in the best position to strike a deal or make connections for
future discussions.

Preceding the opening of the BIO Investor Forum will be the SPARK
Showcase sponsored by the SPARK Program in Translational Research at
Stanford Medicine which aims to advance new biomedical research
discoveries into new treatments for patients. The program and reception
will run from 1PM to 6:30PM (PT). More information can be found here.

Media
registration
is now open. It is complimentary for qualified
reporters.

About BIO

BIO is the world's largest trade association representing biotechnology
companies, academic institutions, state biotechnology centers and
related organizations across the United States and in more than 30 other
nations. BIO members are involved in the research and development of
innovative healthcare, agricultural, industrial and environmental
biotechnology products. BIO also produces the BIO
International Convention
, the world's largest gathering of the
biotechnology industry, along with industry-leading investor and
partnering meetings held around the world. BIOtechNOW is
BIO's blog chronicling "innovations transforming our world" and the BIO
Newsletter is the organization's bi-weekly email newsletter. Subscribe
to the BIO Newsletter
.

Upcoming BIO Events

 

BIO
Latin America Conference

   

BIO
Patient and Health Advocacy Summit

September 4-5, 2018

October 25-26, 2018
Sao Paulo, Brazil     Washington, DC

BIO
Investor Forum

October 17-18, 2018
San Francisco    

 

 

View Comments and Join the Discussion!